Ji'nan Hi-tech Zone accelerates "Chinese Medicine Valley"
Author: Zhu Lei source: Ji'nan daily
country (Shandong) major new drug creation platform. National (Shandong) innovative drug incubator base effect map
" The major new drug project - the national science and Technology Major - the national comprehensive new drug research and development technology platform and the national innovative drug hatching base (hereinafter referred to as "a platform, a base") have started the foundation in Ji'nan hi-tech zone. What will be the role of the two big brand signboards to the bio pharmaceutical industry in Shandong? What is the progress?
according to the deployment of the national medium and long term plan for science and technology development (2006-2020 years) formulated by the State Council, the state has identified 16 major projects, such as large aircraft, manned spaceflight and lunar exploration project, and major new drug creation. The overall goal of the creation of major new drugs is to speed up the historical and strategic transformation of Chinese drug research and pharmaceutical industry from imitation to independent innovation, and to promote China's gradual development from a "pharmaceutical country" to a "medical power". It is understood that the major new drug creation has set up 5 items of "research and development of innovative drugs", "technological transformation of large varieties of drugs", "construction of innovative drug research and development technology platform", "construction of pharmaceutical incubating bases for enterprises" and "Research on key technologies for new drug research and development", and the specific implementation years have been made up to 2020. The construction of the technical platform is the most important. The state invested 6 billion 600 million yuan during the "11th Five-Year" period, which approved the establishment of a large platform for the creation of new drugs in 15 countries, and Shandong was the first to seize the opportunity by virtue of its strong strength.
the construction of the national comprehensive new drug research and development technology platform consists of twelve unit sub platforms. At present, eight sub platforms have been built in the Shandong University and other units. The other four specialized technical platforms will be built in the platform center of the Ji'nan high tech Zone. After the completion of the platform, the development of research and development resources such as Shandong University, provincial pharmacy Institute and medical college will be integrated to form a complete public service support platform for bio pharmaceutical industry from compound discovery to clinical trial and industrialization, which will greatly reduce the cost of research and development of bio pharmaceutical research institutions and enterprises in the province. It will play a positive role in accelerating the transformation of biotechnology achievements and enhancing the capability of independent innovation.
the national innovative drug hatching base will focus on the advantages of famous brands, well-known enterprises, research and development institutions and the headquarters of the group, with the support of improving the service system, legal guarantee, financing mechanism and infrastructure, and making efforts to create a world class and domestic leading innovative drug hatching base. At the end of 12th Five-Year, 100 projects were introduced into the national level platform conversion project, 200 incubated enterprises were introduced, 1000 projects were completed and 30 billion yuan of annual sales revenue was realized in the bio pharmaceutical industry. "One platform and one base" has been started construction recently, with a total construction area of 290 thousand square meters and a total estimated investment of 1 billion 200 million yuan.
Shandong is a major province of medicine in China. The output value of pharmaceuticals has been the first in China for six consecutive years. In 2009, the total sales, profits and taxes and profits of the pharmaceutical industry accounted for more than 20% of the whole country. However, there are still many bottlenecks in building a strong medicine Province in Shandong. The independent innovation ability of new drugs is relatively low, and there is a shortage of new drug varieties and high-end innovation teams. Experts say that the construction of "one platform and one base" has brought great opportunities for the development of bio pharmaceutical industry in our province, which will greatly promote Shandong's leap from "pharmaceutical province" to "medicine strong province".
Ji'nan high tech Zone is an important gathering area of Shandong bio pharmaceutical industry. At present, there are nearly 100 pharmaceutical R & D and production enterprises and high concentration of professional and technical personnel. It is the main core area of new drug research and development in Shandong. It converge to a group of leading enterprises such as Qilu pharmaceutical, BBO Frieda and so on. According to statistics, in 2009, the sales revenue of the high-tech zone was 6 billion yuan, the total profit and tax amount was nearly 1 billion 800 million yuan, and the tax revenue of the high-tech zone 33% came from the pharmaceutical industry. The "one platform, one base", a rare and important innovation resource, and the accumulation of biological and pharmaceutical industry in high and new zones in the past decade, and the strong scientific research power of the large courtyard in the province can be used. The Ji'nan high tech Zone has the leading advantage in realizing the leap development of the bio pharmaceutical industry. At present, the region is firmly seized of this great opportunity to fully promote the planning, construction and investment of the Ji'nan biological medicine Park, and has achieved some results.
it is reported that the target of Ji'nan bio pharmaceutical park is to cultivate and build an enterprise innovation cluster in the bio pharmaceutical industry by taking the national major new drug creation platform as the support, taking the medical professional incubator as the carrier, inviting the domestic and foreign famous pharmaceutical enterprises through the endogenous incubating high growth enterprises and the extension. The layout of development is the trend of "three in one" and "go hand in hand" with each other's main function orientation and industrial internal connection. That is: to remould, improve and upgrade the 1.5 square kilometer medical industrial built-up area in the central area of the high and new zone, establish the incubating area for new drugs, build a new 290 thousand square meter pilot base in the High-tech Zone export processing area, and build a 10000 mu raw material medicine Park industrial area in the two river areas. From the three regions, the integrated pharmaceutical innovation and development industry system is built up from innovative drug R & D, pilot, incubating to industrial chain and industrial chain, forming a new industry development model with innovation promoting industry and industry promoting innovation as a strong independent innovation ability and pharmaceutical innovation enterprise The "Chinese Medicine Valley" that integrates and marketing logistics.
at present, the construction of the two phase of the national comprehensive new drug research and development technology of the national comprehensive drug research and development technology, and the construction of the Ji'nan biological medicine garden in China, which undertake the transformation, hatching and industrialization of innovative drugs, have been carried out simultaneously. Next, the hi-tech zone will adhere to the high level planning, the high standard construction, the scientific organization construction, the acceleration of the project implementation, and further increase the investment and resource integration, and make every effort to introduce the world's advanced and domestic first-class projects and technologies to speed up the cultivation of the bio pharmaceutical industry cluster and form a country with close combination of production, learning and research. The pharmaceutical innovation system has made a positive contribution to building Ji'nan's strategic emerging industries and improving the overall strength of new drugs in our province.